431 related articles for article (PubMed ID: 34512145)
21. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.
Zhang EB; Yin DD; Sun M; Kong R; Liu XH; You LH; Han L; Xia R; Wang KM; Yang JS; De W; Shu YQ; Wang ZX
Cell Death Dis; 2014 May; 5(5):e1243. PubMed ID: 24853421
[TBL] [Abstract][Full Text] [Related]
22. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.
Gautam N; Kaur M; Kaur S
J Cancer Res Ther; 2021; 17(2):311-326. PubMed ID: 33063698
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
24. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.
Lu H; Li G; Zhou C; Jin W; Qian X; Wang Z; Pan H; Jin H; Wang X
Am J Cancer Res; 2016; 6(12):2737-2754. PubMed ID: 28042497
[TBL] [Abstract][Full Text] [Related]
25. Going beyond Polycomb: EZH2 functions in prostate cancer.
Park SH; Fong KW; Mong E; Martin MC; Schiltz GE; Yu J
Oncogene; 2021 Sep; 40(39):5788-5798. PubMed ID: 34349243
[TBL] [Abstract][Full Text] [Related]
26. The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S; Gholami MH; Hushmandi K; Hashemi F; Zabolian A; Canadas I; Zarrabi A; Nabavi N; Aref AR; Crea F; Wang Y; Ashrafizadeh M; Kumar AP
J Hematol Oncol; 2022 Mar; 15(1):18. PubMed ID: 35236381
[TBL] [Abstract][Full Text] [Related]
27. Down-regulated lncRNA MEG3 promotes osteogenic differentiation of human dental follicle stem cells by epigenetically regulating Wnt pathway.
Deng L; Hong H; Zhang X; Chen D; Chen Z; Ling J; Wu L
Biochem Biophys Res Commun; 2018 Sep; 503(3):2061-2067. PubMed ID: 30103943
[TBL] [Abstract][Full Text] [Related]
28. EZH2-Targeted Therapies in Cancer: Hype or a Reality.
Eich ML; Athar M; Ferguson JE; Varambally S
Cancer Res; 2020 Dec; 80(24):5449-5458. PubMed ID: 32978169
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B
Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776
[TBL] [Abstract][Full Text] [Related]
30. LncRNA JPX targets SERCA2a to mitigate myocardial ischemia/reperfusion injury by binding to EZH2.
Bao J; Zhang C; Chen J; Xuan H; Wang C; Wang S; Yin J; Liu Y; Li D; Xu T
Exp Cell Res; 2023 Jun; 427(1):113572. PubMed ID: 36990422
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of p21 by long non-coding RNA HOTAIR is involved in the cell cycle disorder induced by cigarette smoke extract.
Liu Y; Wang B; Liu X; Lu L; Luo F; Lu X; Shi L; Xu W; Liu Q
Toxicol Lett; 2016 Jan; 240(1):60-7. PubMed ID: 26506537
[TBL] [Abstract][Full Text] [Related]
32. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin.
Kaneko S; Bonasio R; Saldaña-Meyer R; Yoshida T; Son J; Nishino K; Umezawa A; Reinberg D
Mol Cell; 2014 Jan; 53(2):290-300. PubMed ID: 24374312
[TBL] [Abstract][Full Text] [Related]
33. Binding interactions between long noncoding RNA HOTAIR and PRC2 proteins.
Wu L; Murat P; Matak-Vinkovic D; Murrell A; Balasubramanian S
Biochemistry; 2013 Dec; 52(52):9519-27. PubMed ID: 24320048
[TBL] [Abstract][Full Text] [Related]
34. Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer.
Chen M; Zheng Y; Xie J; Zhen E; Zhou X
Anticancer Drugs; 2020 Sep; 31(8):792-798. PubMed ID: 32304409
[TBL] [Abstract][Full Text] [Related]
35. Targeting EZH2 as cancer therapy.
Hanaki S; Shimada M
J Biochem; 2021 Sep; 170(1):1-4. PubMed ID: 33479735
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
[TBL] [Abstract][Full Text] [Related]
37. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X
J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150
[TBL] [Abstract][Full Text] [Related]
38. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.
Qi Y; Ooi HS; Wu J; Chen J; Zhang X; Tan S; Yu Q; Li YY; Kang Y; Li H; Xiong Z; Zhu T; Liu B; Shao Z; Zhao X
Oncotarget; 2016 Mar; 7(11):12693-703. PubMed ID: 26871474
[TBL] [Abstract][Full Text] [Related]
39. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Cheng Y; Song Z; Fang X; Tang Z
Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
[TBL] [Abstract][Full Text] [Related]
40. Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer.
Nouruzi S; Tabrizian N; Zoubeidi A
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36718085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
